Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1897813

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1897813

NGS Sample Preparation Market Size, Share, and Growth Analysis, By Products & Services (Workstations/Instruments, Reagents & Consumables), By Workflow, By Sample Type, By Method, By Application, By End User, By Region - Industry Forecast 2026-2033

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

NGS Sample Preparation Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.4 Billion in 2025 to USD 7.02 Billion by 2033, growing at a CAGR of 14.32% during the forecast period (2026-2033).

The global NGS (Next-Generation Sequencing) sample preparation market is experiencing substantial growth, driven by the increasing adoption of high-throughput sequencing technologies. This essential process involves preparing DNA or RNA samples, ensuring the accuracy and quality of sequencing outcomes. The demand for NGS sample preparation is propelled by its ability to provide critical insights into genetic material and biological functions. Innovations in nanotechnology, such as nano-sized magnetic beads, nanofluidics, and microfluidics, are reshaping the landscape of sample preparation. These cutting-edge techniques optimize efficiency by enabling quicker and more precise processing, ultimately reducing costs and turnaround times. As a result, NGS sample preparation is becoming more accessible to a wider range of researchers and clinicians, fueling market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the NGS Sample Preparation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

NGS Sample Preparation Market Segments Analysis

Global NGS Sample Preparation Market is segmented by Products & Services, Workflow, Sample Type, Method, Application, End User and Region. Based on Products & Services, the market is segmented into Workstations/Instruments, Reagents & Consumables, Services. Based on Workflow, the market is segmented into DNA Fragmentation & Library Preparation, Target Enrichment, Quality Control. Based on Sample Type, the market is segmented into DNA, RNA. Based on Method, the market is segmented into Manual Sample Preparation, Microfluidic Sample Preparation, Automated Liquid Handling-based Sample Preparation. Based on Application, the market is segmented into Disease Diagnostics (Cancer Diagnostics, Reproductive Health Diagnostics, Infectious Disease Diagnostics, Others), Drug Discovery, Agricultural & Animal Research, Others. Based on End User, the market is segmented into Hospitals & Clinics, Academic Institutes & Research Centers, Pharma & Biotech Companies, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the NGS Sample Preparation Market

The NGS sample preparation market is propelled by its essential function in a wide range of genomic research applications, including gene expression analysis, variant detection, biomarker discovery, and metagenomics. As advancements in genomics progress, there is an increasing necessity for efficient, high-throughput sample preparation techniques tailored for next-generation sequencing. This surge in demand underscores the importance of developing innovative methods that enhance the speed and reliability of sample processing, thereby supporting the broader goals of genomic research and enabling scientists to uncover critical insights into genetic material. The continuous evolution of these technologies further drives market growth and research capabilities.

Restraints in the NGS Sample Preparation Market

The NGS Sample Preparation market faces significant challenges due to the enormous data volumes generated by next-generation sequencing. This data influx demands sophisticated bioinformatics tools and extensive storage solutions, complicating the analysis and management of genomic datasets. A skilled workforce of bioinformaticians is essential for navigating these complexities, alongside the need for a robust infrastructure and secure storage systems. These requirements can create barriers that hinder the widespread adoption and efficient implementation of NGS sample preparation techniques, ultimately limiting their accessibility and effectiveness in various genomic research and clinical applications.

Market Trends of the NGS Sample Preparation Market

A notable trend shaping the global Next-Generation Sequencing (NGS) sample preparation market is the escalating shift towards automated and high-throughput solutions. This movement is propelled by the necessity for efficient, scalable approaches to manage the increasing volume of samples associated with NGS workflows. Automated sample preparation systems offer significant benefits, including reduced manual intervention, superior reproducibility, heightened accuracy, and increased sample throughput. By integrating advanced robotics and innovative liquid handling technologies, these systems streamline various critical processes, such as DNA/RNA extraction, library preparation, and target enrichment, ultimately enhancing productivity and reliability in genomic analyses.

Product Code: SQMIG35D2097

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Driver & Opportunities
    • Restraints & Challenges
  • Porters Analysis & Impact
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Technological Advancement
  • Regulatory Landscape
  • Patent Analysis
  • Value Chain Analysis
  • Customer & Buying Criteria Analysis
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Market Attractiveness Index
  • Pricing Analysis

Global NGS Sample Preparation Market Size by Products & Services & CAGR (2026-2033)

  • Market Overview
  • Workstations/Instruments
  • Reagents & Consumables
  • Services

Global NGS Sample Preparation Market Size by Workflow & CAGR (2026-2033)

  • Market Overview
  • DNA Fragmentation & Library Preparation
  • Target Enrichment
  • Quality Control

Global NGS Sample Preparation Market Size by Sample Type & CAGR (2026-2033)

  • Market Overview
  • DNA
  • RNA

Global NGS Sample Preparation Market Size by Method & CAGR (2026-2033)

  • Market Overview
  • Manual Sample Preparation
  • Microfluidic Sample Preparation
  • Automated Liquid Handling-based Sample Preparation

Global NGS Sample Preparation Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Disease Diagnostics
    • Cancer Diagnostics
    • Reproductive Health Diagnostics
    • Infectious Disease Diagnostics
    • Others
  • Drug Discovery
  • Agricultural & Animal Research
  • Others

Global NGS Sample Preparation Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals & Clinics
  • Academic Institutes & Research Centers
  • Pharma & Biotech Companies
  • Others

Global NGS Sample Preparation Market Size & CAGR (2026-2033)

  • North America (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • US
    • Canada
  • Europe (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Products & Services, Workflow, Sample Type, Method, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

  • Illumina, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agilent Technologies, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Becton, Dickinson and Company
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qiagen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Promega Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Eurofins Scientific
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BGI Group
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • 10x Genomics
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sysmex Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Psomagen
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zymo Research Corporation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Takara Holdings Inc
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nanjing Novogene Bio Technology Co., Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • New England Biolabs
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendation

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!